{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:19:59Z","timestamp":1783678799369,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["patient-research.elsevier.com","nucmedbio.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.nucmedbio.2014.03.016","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T23:05:37Z","timestamp":1396307137000},"page":"495-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Synthesis and evaluation of 18F-labeled bile acid compound: A potential PET imaging agent for FXR-related diseases"],"prefix":"10.1016","volume":"41","author":[{"given":"Lina","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI106232","article-title":"Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey","volume":"49","author":"Dowling","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0010","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: Chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-0760(99)00099-0","article-title":"Down-regulation of the rat hepatic sterol 27-hydroxylase gene by bile acids in transfected primary hepatocytes: possible role of hepatic nuclear factor 1 alpha","volume":"70","author":"Rao","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0025","doi-asserted-by":"crossref","first-page":"17707","DOI":"10.1074\/jbc.M411771200","article-title":"Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids","volume":"280","author":"Yu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0030","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: Opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0040","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0045","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.bmc.2011.03.004","article-title":"Extending SAR of bile acids as FXR ligands: Discovery of 23-N-(carbocinnamyloxy)-3alpha, 7alpha-dihydroxy-6 alpha-ethyl-24-nor-5 beta-cholan-23-amine","volume":"19","author":"Gioiello","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1074\/jbc.M209505200","article-title":"Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0055","doi-asserted-by":"crossref","first-page":"27703","DOI":"10.1074\/jbc.M302128200","article-title":"Farnesoid X receptor regulates bile acid-amino acid conjugation","volume":"278","author":"Pircher","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1121435","article-title":"Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration","volume":"312","author":"Huang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","article-title":"Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice","volume":"28","author":"Kim","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0075","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.108.145409","article-title":"Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development","volume":"328","author":"Maran","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0090","doi-asserted-by":"crossref","first-page":"11323","DOI":"10.1073\/pnas.0604772103","article-title":"Benefit of farnesoid X receptor inhibition in obstructive cholestasis","volume":"103","author":"Stedman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0095","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbalip.2006.09.018","article-title":"Effects of FXR in foam-cell formation and atherosclerosis development","volume":"1761","author":"Guo","year":"2006","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0105","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/hep.25905","article-title":"Promotion of Liver Regeneration\/Repair by Farnesoid X Receptor in Both Liver and Intestine in Mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.gastro.2003.12.013","article-title":"Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity","volume":"126","author":"Chen","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1023\/B:DDAS.0000034558.78747.98","article-title":"The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer","volume":"49","author":"De Gottardi","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0120","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3748\/wjg.14.2010","article-title":"Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients","volume":"14","author":"Takahara","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0125","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2353\/ajpath.2009.090114","article-title":"Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts","volume":"175","author":"Fickert","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.111.179390","article-title":"Increased Activation of the Wnt\/beta-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice","volume":"338","author":"Wolfe","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0135","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ijc.26293","article-title":"Expression of the nuclear bile acid receptor\/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis","volume":"130","author":"Lax","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0140","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jhep.2012.06.016","article-title":"Deletion of IFN gamma enhances hepatocarcinogenesis in FXR knockout mice","volume":"57","author":"Meng","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-kappa B and the hepatic inflammation-fibrosis-cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/me.2011-1383","article-title":"Hepatocarcinogenesis in FXR-\/- Mice Mimics Human HCC Progression That Operates through HNF1 alpha Regulation of FXR Expression","volume":"26","author":"Liu","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0155","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0160","first-page":"579","article-title":"Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation","volume":"10","author":"Fiorucci","year":"2010","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2967\/jnumed.111.098731","article-title":"N-Methyl-C-11 Cholylsarcosine, a Novel Bile Acid Tracer for PET\/CT of Hepatic Excretory Function: Radiosynthesis and Proof-of-Concept Studies in Pigs","volume":"53","author":"Frisch","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0170","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1021\/jm0310683","article-title":"Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance Imaging","volume":"47","author":"Anelli","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0175","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0185","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: Natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0190","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1021\/jm060294k","article-title":"Back door modulation of the farnesoid X receptor: Design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives","volume":"49","author":"Pellicciari","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0195","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1016\/j.tetlet.2006.06.176","article-title":"Click for PET: rapid preparation of F-18 fluoropeptides using Cu-I catalyzed 1,3-dipolar cycloaddition","volume":"47","author":"Marik","year":"2006","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0200","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.nucmedbio.2011.12.002","article-title":"Synthesis and evaluation of nucleoside radiotracers for imaging proliferation","volume":"39","author":"Smith","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.apradiso.2013.01.033","article-title":"Fluorine-18 labeling by click chemistry: Multiple probes in one pot","volume":"75","author":"Jia","year":"2013","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0210","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1016\/j.bmc.2010.06.070","article-title":"Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands","volume":"18","author":"Baumann","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1021\/bc00008a007","article-title":"Hepatobiliary delivery of polyaminopolycarboxylate chelates-synthesis and characterization of a cholic-acid conjugate of EDTA and biodistribution and imaging studies with its In-111 chelate","volume":"2","author":"Betebenner","year":"1991","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0220","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.bmc.2012.01.002","article-title":"New fluorescent bile acids: Synthesis, chemical characterization, and disastereoselective uptake by Caco-2 cells of 3-deoxy 3-NBD-amino deoxycholic and ursodeoxycholic acid","volume":"20","author":"Majer","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0225","first-page":"51","article-title":"Cu-I-catalyzed alkyne-azide \"click\" cycloadditions from a mechanistic and synthetic perspective","author":"Bock","year":"2005","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.nucmedbio.2014.03.016_bb0230","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1021\/cr0783479","article-title":"Cu-catalyzed azide-alkyne cycloaddition","volume":"108","author":"Meldal","year":"2008","journal-title":"Chem Rev"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T02:55:17Z","timestamp":1538708117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805114000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0969805114000912"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.03.016","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of 18F-labeled bile acid compound: A potential PET imaging agent for FXR-related diseases","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}